Cibus logo

Cibus Share Price Today

(NASDAQ: CBUS)

Cibus share price is $2.23 & ₹193.94 as on 6 Mar 2025, 2.30 'hrs' IST

$2.23

0.27

(13.78%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cibus share price in Dollar and Rupees. Guide to invest in Cibus stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cibus, along with analyst recommendations, forecasts, and comprehensive financials.

Cibus share price movements

  • Today's Low: $1.96
    Today's High: $2.42

    Day's Volatility :19.01%

  • 52 Weeks Low: $1.80
    52 Weeks High: $23.18

    52 Weeks Volatility :92.22%

Cibus (CBUS) Returns

PeriodCibus IncIndex (Russel 2000)
3 Months
-50.32%
0.0%
6 Months
-57.21%
0.0%
1 Year
-89.39%
0.0%
3 Years
-92.48%
-11.6%

Cibus (CBUS) Key Statistics

in dollars & INR

Previous Close
$1.96
Open
$1.95
Today's High
$2.42
Today's Low
$1.96
Market Capitalization
$63.7M
Today's Volume
$37.5K
52 Week High
$23.18
52 Week Low
$1.8036
Revenue TTM
$4.2M
EBITDA
$-60.3M
Earnings Per Share (EPS)
$-45.95
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-149.74%

How to invest in Cibus Stock (CBUS) from India?

It is very easy for Indian residents to invest directly in Cibus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cibus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cibus or CBUS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cibus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cibus shares which would translate to 0.390 fractional shares of Cibus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cibus, in just a few clicks!

Returns in Cibus (CBUS) for Indian investors in Rupees

The Cibus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cibus investment value today

Current value as on today

₹17,036

Returns

₹82,964

(-82.96%)

Returns from Cibus Stock

₹87,926 (-87.93%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Cibus (CBUS)

-42%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cibus Stock from India on INDmoney has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Cibus

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Cibus(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Cibus Stock (CBUS)

What analysts predicted

Upside of 690.36%

Target:

$17.63

Current:

$2.23

Insights on Cibus Stock (Ticker Symbol: CBUS)

  • Price Movement

    In the last 3 months, CBUS stock has moved down by -50.3%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 545.0K → 1.66M (in $), with an average increase of 42.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -23.43M → -179.96M (in $), with an average decrease of 314.7% per quarter
  • CBUS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 151.5%
  • Price to Sales

    ForCBUS every $1 of sales, investors are willing to pay $9.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

CBUS Cibus Financials in INR & Dollars

FY18Y/Y Change
Revenue
$236.0K
↓ 53.54%
Net Income
$-27.9M
↑ 7.38%
Net Profit Margin
-11.8K%
↓ 6706.59%
FY19Y/Y Change
Revenue
$7.3M
↑ 2991.53%
Net Income
$-39.6M
↑ 41.99%
Net Profit Margin
-542.93%
↑ 11277.83%
FY20Y/Y Change
Revenue
$23.9M
↑ 226.91%
Net Income
$-44.8M
↑ 13.19%
Net Profit Margin
-187.98%
↑ 354.95%
FY21Y/Y Change
Revenue
$26.0M
↑ 8.96%
Net Income
$-29.2M
↓ 34.88%
Net Profit Margin
-112.36%
↑ 75.62%
FY22Y/Y Change
Revenue
$157.0K
↓ 99.4%
Net Income
$-16.9M
↓ 42.15%
Net Profit Margin
-10.8K%
↓ 10646.24%
FY23Y/Y Change
Revenue
$1.8M
↑ 1057.32%
Net Income
$-267.6M
↑ 1484.44%
Net Profit Margin
-14.7K%
↓ 3970.46%
Q2 FY23Q/Q Change
Revenue
$197.0K
↑ 369.05%
Net Income
$-20.5M
↑ 280.22%
Net Profit Margin
-10.4K%
↑ 2432.2%
Q3 FY23Q/Q Change
Revenue
$475.0K
↑ 141.12%
Net Income
$-34.5M
↑ 68.36%
Net Profit Margin
-7.3K%
↑ 3141.61%
Q4 FY23Q/Q Change
Revenue
$1.1M
↑ 132.21%
Net Income
$-207.2M
↑ 500.08%
Net Profit Margin
-18.8K%
↓ 11515.72%
Q1 FY24Q/Q Change
Revenue
$545.0K
↓ 50.59%
Net Income
$-23.4M
↓ 88.69%
Net Profit Margin
-4.3K%
↑ 14484.77%
Q2 FY24Q/Q Change
Revenue
$838.0K
↑ 53.76%
Net Income
$-24.9M
↑ 6.18%
Net Profit Margin
-3.0K%
↑ 1330.67%
Q3 FY24Q/Q Change
Revenue
$1.7M
↑ 98.93%
Net Income
$-180.0M
↑ 623.26%
Net Profit Margin
-10.8K%
↓ 7826.59%
FY18Y/Y Change
Profit
$-845.0K
↑ 1865.12%
FY19Y/Y Change
Profit
$-2.0M
↑ 134.79%
FY20Y/Y Change
Profit
$-11.3M
↑ 468.35%
FY21Y/Y Change
Profit
$-2.6M
↓ 77.21%
FY22Y/Y Change
Profit
$157.0K
↓ 106.11%
FY23Y/Y Change
Profit
$1.4M
↑ 805.73%
Q2 FY23Q/Q Change
Profit
$-529.0K
↑ 19.14%
Q3 FY23Q/Q Change
Profit
$-1.2M
↑ 128.54%
Q4 FY23Q/Q Change
Profit
$1.0M
↓ 185.36%
Q1 FY24Q/Q Change
Profit
$-1.2M
↓ 218.41%
Q2 FY24Q/Q Change
Profit
$-895.0K
↓ 26.76%
Q3 FY24Q/Q Change
Profit
$1.7M
↓ 286.26%
FY19Y/Y Change
Operating Cash Flow
$-32.0M
↑ 57.77%
Investing Cash Flow
$-3.0M
-
Financing Cash Flow
$-330.0K
↓ 100.54%
FY20Y/Y Change
Operating Cash Flow
$-43.7M
↑ 36.68%
Investing Cash Flow
$-13.5M
↑ 354.16%
Financing Cash Flow
$15.4M
↓ 4768.79%
FY21Y/Y Change
Operating Cash Flow
$-18.8M
↓ 56.93%
Investing Cash Flow
$11.2M
↓ 183.07%
Financing Cash Flow
$3.7M
↓ 75.71%
FY22Y/Y Change
Operating Cash Flow
$-19.4M
↑ 2.94%
Investing Cash Flow
$-1.5M
↓ 113.57%
Financing Cash Flow
$10.0M
↑ 166.94%
Q2 FY23Q/Q Change
Operating Cash Flow
$-11.7M
↑ 394.48%
Investing Cash Flow
$58.8M
↑ 0.0%
Financing Cash Flow
$1.8M
↑ 94.8%

Cibus Technicals Summary

Sell

Neutral

Buy

Cibus is currently in a neutral trading position according to technical analysis indicators.

Cibus (CBUS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cibus Inc logo
-22.22%
-57.21%
-89.39%
-92.48%
-92.48%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cibus Inc logo
NA
NA
NA
-6.88
-1.5
-0.07
NA
4.09
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cibus Inc logo
Buy
$63.7M
-92.48%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Cibus

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
Organization
Cibus
Employees
183
CEO
Mr. Sean O'Connor Ph.D.
Industry
Chemicals: Agricultural

Management People of Cibus

NameTitle
Mr. Rory Balfour Riggs M.B.A.
Co-Founder & Chairman
Dr. Peter Beetham B.Sc., Ph.D.
Co-Founder, Interim CEO, President, COO & Director
Dr. Greg Gocal Ph.D.
Co-Founder, Chief Scientific Officer & Executive VP
Mr. Carlo Broos M.Sc.
Interim Chief Financial Officer
Mr. Jason Stokes J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
Ms. Rosa Cheuk Kim J.D.
Senior Vice President of Legal
Dr. James Radtke Ph.D.
Senior Vice President of Product Development
Mr. Tony Moran
Senior Vice President of International Development
Ms. Noel Sauer Ph.D.
Senior Vice President of Research
Mr. Sean O'Connor Ph.D.
Senior VP and President & CEO of Nucelis

Important FAQs about investing in CBUS Stock from India :

What is Cibus share price today?

Cibus share price today stands at $2.23, Open: $1.95 ; Previous Close: $1.96 ; High: $2.42 ; Low: $1.96 ; 52 Week High: $23.18 ; 52 Week Low: $1.80.

The stock opens at $1.95, after a previous close of $1.96. The stock reached a daily high of $2.42 and a low of $1.96, with a 52-week high of $23.18 and a 52-week low of $1.80.

Can Indians buy Cibus shares?

Yes, Indians can invest in the Cibus (CBUS) from India.

With INDmoney, you can buy Cibus at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cibus at zero transaction cost.

How can I buy Cibus shares from India?

It is very easy to buy Cibus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cibus (CBUS) be purchased?

Yes, you can buy fractional shares of Cibus with INDmoney app.

What are the documents required to start investing in Cibus stocks?

To start investing in Cibus, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cibus Stock (CBUS)?

Today’s highest price of Cibus (CBUS) is $2.42.

Today’s lowest price of Cibus (CBUS) is $1.96.

What is today's market capitalisation of Cibus?

Today's market capitalisation of Cibus CBUS is 63.7M

What is the 52 Week High and Low Range of Cibus Stock (CBUS)?

  • 52 Week High

    $23.18

  • 52 Week Low

    $1.80

What are the historical returns of Cibus (CBUS)?

  • 1 Month Returns

    -22.22%

  • 3 Months Returns

    -57.21%

  • 1 Year Returns

    -89.39%

  • 5 Years Returns

    -92.48%

Who is the Chief Executive Officer (CEO) of Cibus ?

Mr. Sean O'Connor Ph.D. is the current Chief Executive Officer (CEO) of Cibus.